The drug is a innovative antibody, specifically designed as the fully human therapeutic antibody targeting DLL canonical ligand 3 (DLL3), who has a key part in hematopoietic root lineage maturation and cancer https://dalotuzumabrecombinantma828384.wikiannouncement.com/user